Oral Presentations:

DATE/TIME: May 31, 3:45 PM – 3:57 PM
TITLE: Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation
LOCATION: S100bc | Live Stream
ABSTRACT #: 6503
SENIOR AUTHOR: Antonio Jimenez Jimenez

DATE/TIME: May 31, 5:09 PM – 5:21 PM
TITLE: Safety and efficacy of first-in-class CXCR1/2 inhibitor SX-682 in combination with pembrolizumab (pem) in patients (pts) with metastatic melanoma (mMEL) with disease progression on anti–PD-1 therapy
LOCATION: Hall D1 | Live Stream
ABSTRACT #: 9508
CO-AUTHOR: Leonel Hernandez-Aya

Oral Presentations:

DATE/TIME: June 1, 8:00 AM – 8:06 AM
TITLE: Preliminary safety and efficacy of oral azacitidine (Oral-AZA) in patients (pts) with low-/Intermediate (Int)-risk myelodysplastic syndromes (MDS): Phase 2 results from the ASTREON trial
LOCATION: E450b | On Demand
ABSTRACT #: 6509
CO-AUTHOR: Mikkael Sekeres

DATE/TIME: June 1, 1:27 PM – 1:39 PM
TITLE: International medical graduates (IMG) representation at international oncology conference meetings
LOCATION: S100bc | Live Stream
ABSTRACT#: 9000
CO-AUTHOR: Gilberto Lopes

DATE/TIME: June 1, 1:39 PM – 1:51 PM
TITLE: Going back home: Understanding the challenges of international medical graduates (IMGs) in oncology
LOCATION: S100bc | Live Stream
ABSTRACT#: 9001
CO-AUTHOR: Coral Olazagasti

DATE/TIME: June 1, 3:15 PM - 3:30 PM
TITLE: How Social Media Advances Research and Promotes Professional Development
LOCATION: S402 - On Demand
CO-AUTHOR: Gilberto Lopes

DATE/TIME: June 1, 5:00 PM - 5:12 PM
TITLE: Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma.
LOCATION: S100bc | Live Stream
ABSTRACT #: 7006
CO-AUTHOR: Georgios Pongas

DATE/TIME: June 2, 8:00 PM
TITLE: Miami Nights, Sylvester's reception during ASCO
LOCATION: Pendry Chicago
RSVP: Sylvester.org/MiamiNights

Oral Presentations:

DATE/TIME: June 3, 9:00 AM – 9:12 AM
TITLE: Biomarker analyses in patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial
LOCATION: Hall B1
ABSTRACT #: 4504
CO-AUTHOR: Jaime Merchan

DATE/TIME: June 3, 9:45 AM – 9:51 AM
TITLE: Phase II multi-center study of adjuvant nivolumab in combination with ipilimumab in patients with high-risk uveal melanoma (HCRN MEL17-309).
LOCATION: S406 | On Demand
ABSTRACT #: 9509
CO-AUTHOR: Leonel Hernandez-Aya

DATE/TIME: June 3, 10:57 AM – 11:03 AM
TITLE: Assessing gender disparities in oncology: Less talk, more action.
LOCATION: E450a | On Demand
ABSTRACT #: 9011
CO-AUTHOR: Coral Olazagasti

DATE/TIME: June 3, 12:42 PM – 12:48 PM
TITLE: Outcomes of advanced/metastatic breast cancer (aMBC) treated with BRIA-IMT, an allogeneic whole cell immunotherapy
LOCATION: Hall D1 | Live Stream
ABSTRACT #: 1022
AUTHOR: Carmen Calfa

DATE/TIME: June 3, 3:12 PM – 3:24 PM
TITLE: StrateGIST 1: A first-in-human (FIH), phase 1 study of IDRX-42 in patients with metastatic gastrointestinal stromal tumors resistant to prior treatment with tyrosine kinase inhibitors (TKIs)
LOCATION: S100bc | Live Stream
ABSTRACT #: 11501
CO-AUTHOR: Jonathan Trent

DATE/TIME: June 3, 3:36 PM – 3:48 PM
TITLE: The More the Better? Quadruplets in Newly Diagnosed Multiple Myeloma
LOCATION: Hall D1 | Live Stream
ABSTRACT #: Abstracts Discussion 7500-7502
CO-AUTHOR: Carl Ola Landgren

TITLE: The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in small-cell lung cancer (SCLC).
LOCATION: poster board # 273
ABSTRACT #: 3128
AUTHOR: Samuel Kareff
CO-AUTHORS: Aman Chauhan, Gilberto Lopes

TITLE: A phase II randomized control trial of triapine plus lutetium 177 DOTATATE versus lutetium 177 DOTATATE alone for well-differentiated somatostatin receptor-positive neuroendocrine tumors.
LOCATION: poster board # 171a
ABSTRACT #: TPS4202
CO-AUTHOR: Aman Chauhan

TITLE: Interim analysis of ABM-1310, a blood-brain barrier-penetrant BRAF inhibitor, in patients with BRAF V600-mutated solid tumors.
LOCATION: poster board # 252
ABSTRACT #: 3107
CO-AUTHOR: Macarena de la Fuente